111 (YI) Interest & Investment Income (2017 - 2025)
111 (YI) reported Interest & Investment Income of $133000.0 for Q4 2025, down 33.83% on a YoY basis from $201000.0 in Q4 2024, and up 38.54% sequentially from $96000.0 in Q3 2025.
111 (YI) Interest & Investment Income (2017 - 2025) Analysis & Trends
111 (YI) has 9 years of Interest & Investment Income data on file, last reported at $133000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 33.83% year-over-year to $133000.0; the trailing twelve-month figure through Dec 2025 stood at $544000.0 (down 44.32% YoY), and the FY2025 full-year result was $556000.0, down 42.38% from the prior year.
- Interest & Investment Income climbed to $133000.0 in Q4 2025, from $96000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $476000.0 in Q2 2021 to a low of $96000.0 in Q3 2025.
- A 5-year average of $273400.0 and a median of $285000.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 1058.54% in 2021 and sank 55.96% in 2025, its largest moves.
- Tracing YI's Interest & Investment Income over 5 years: stood at $245000.0 in 2021, then climbed by 24.08% to $304000.0 in 2022, then advanced by 7.24% to $326000.0 in 2023, then plunged by 38.34% to $201000.0 in 2024, then plunged by 33.83% to $133000.0 in 2025.
- Business Quant data shows YI's Interest & Investment Income at $133000.0 in Q4 2025, $96000.0 in Q3 2025, and $142000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | - |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | - |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | - |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 7.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 133,000.00 |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | - |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | - |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 46,673.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 133,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Sep 30, 2023 | 324,000.00 |
| Jun 30, 2023 | 304,000.00 |
| Mar 31, 2023 | 284,000.00 |
| Dec 31, 2022 | 304,000.00 |
| Sep 30, 2022 | 360,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 322,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 315,000.00 |
| Jun 30, 2021 | 476,000.00 |
| Mar 31, 2021 | 475,000.00 |